The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

Policy Notices

• Notice to Extend PA-18-795
  (NOT-HS-23-016)
  Agency for Healthcare Research and Quality

• Notice to Extend PA-18-794
  (NOT-HS-23-017)
  Agency for Healthcare Research and Quality

General Notices

• Notice of Upcoming NIH Early Prediction of Alzheimer's Disease and Alzheimers Disease Related Dementias (AD/ADRD) Open Innovation Challenge
  (NOT-AG-23-040)
  National Institute on Aging

• Pre-Application Webinar for Advancing Cancer Control Equity Research through Transformative Solutions RFAs: RFA-CA-23-026 and RFA-CA-23-027
  (NOT-CA-23-076)
  National Cancer Institute

• Notice of Pre-Application Webinar for Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors (RFA-DK-23-009/RFA-DK-23-010)
  (NOT-DK-23-028)
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Early Expiration and Reissuance of NOT-HL-22-010 "Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups"
  (NOT-HL-23-096)
  National Heart, Lung, and Blood Institute

• NIH Announces the Open Period of FY 2024 Helium-3 Requests for Medical Research
  (NOT-HL-23-098)
  National Heart, Lung, and Blood Institute

• Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-300 Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)
  (NOT-MH-23-355)
  National Institute of Mental Health

• Notice of Technical Assistance Webinar for RFA-MH-24-120, "Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)"
  (NOT-MH-23-360)
  National Institute of Mental Health

• Notice of Participation of the OBSSR in RFA-AT-24-002 "Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-OD-23-154)
  Office of Behavioral and Social Sciences Research

• Findings of Research Misconduct
  (NOT-OD-23-155)
  Office of the Director, NIH

• Request for Information (RFI): National Institute of Dental and Craniofacial Research (NIDCR) Strategic Planning of Infrastructure and Resources for Data Science Research and Research Training
  (NOT-DE-23-008)
  National Institute of Dental and Craniofacial Research

Notice of Changes to Funding Opportunities

• Notice of Correction to NOT-CA-23-071: Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
  (NOT-CA-23-075)
  National Cancer Institute

• Notice Regarding the Data Management and Sharing Plan for Applications Submitted RFA-ES-23-004 Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed
  (NOT-ES-23-012)
  National Institute of Environmental Health Sciences

• Notice of Need to Expire and Reissue RFA-ES-23-004 "Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)"
  (NOT-ES-23-013)
  National Institute of Environmental Health Sciences

• Notice of Participation of the National Eye Institute (NEI) in RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
  (NOT-EY-23-008)
  National Eye Institute

• Notice of Correction to the Instructions for Specific Aims in PAR-23-122 "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
  (NOT-GM-23-023)
  National Institute of General Medical Sciences

• Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-MH-23-330 and RFA-MH-23-331 K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity
  (NOT-MH-23-345)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke

• Notice of Early Expiration of PAR-22-248: HIV/AIDS Scholars Using NHP Models Program (K01 Independent Clinical Trial Not Allowed) and PAR-22-252: Early Stage Investigator HIV/AIDS Research Using NHP Models (R21 Clinical Trial Not Allowed)
  (NOT-OD-23-148)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

• Notice of Change to Application Instructions for RFA-RM-23-007 "NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)"
  (NOT-RM-23-019)
  Office of Strategic Coordination (Common Fund)

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
  (NOT-LM-23-003)
  National Library of Medicine

Notices of Special Interest

• Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data
  (NOT-AA-23-011)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections
  (NOT-AI-23-050)
  National Institute of Allergy and Infectious Diseases

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission to the ASPIRE (A Specialized Platform for Research Exploration) Collaborative Research Program
  (NOT-TR-23-019)
  National Center for Advancing Translational Sciences

Funding Opportunities

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
  (PA-23-189)
  Office of the Director, NIH
  Centers for Disease Control and Prevention
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Institute for Occupational Safety and Health
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Office of Research on Women's Health
   
• NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
  (PAR-23-200)
  National Eye Institute
   
• NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
  (PAR-23-205)
  National Eye Institute
   
• Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  (PAR-23-215)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Mental Health
   
• HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
  (PAR-23-225)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
   
• Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed)
  (PAR-23-234)
  National Institute of Mental Health
   
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
  (PAR-24-023)
  National Institute of Mental Health
   
• Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
  (PAR-24-024)
  National Institute of Mental Health
   
• Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
  (PAR-24-025)
  National Institute of Mental Health
   
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
  (PAR-24-026)
  National Institute of Mental Health
   
• Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed)
  (RFA-AI-23-039)
  National Institute of Allergy and Infectious Diseases
   
• Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-AT-24-002)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Nursing Research
  Office of Disease Prevention
   
• Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
  (RFA-CA-23-026)
  National Cancer Institute
  Application Receipt Date(s): September 14, 2023
• Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
  (RFA-CA-23-027)
  National Cancer Institute
   
• Youth Violence Prevention Interventions (R01 - Clinical Trial Required)
  (RFA-MD-24-002)
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
   
• Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed)
  (RFA-MH-24-100)
  National Institute of Mental Health
   
• Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
  (RFA-NS-24-009)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
   
• Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed)
  (RFA-NS-24-025)
  National Institute of Neurological Disorders and Stroke
  
  Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).